Home » Conatus Pharma Begins Phase IIb Trial of Emricasan in ACLF Patients
Conatus Pharma Begins Phase IIb Trial of Emricasan in ACLF Patients
Conatus Pharma has initiated a Phase IIb trial of emricasan, a drug that the company hopes will prove efficient in combating acute-on-chronic liver failure.
Pharmabiz.com
Pharmabiz.com
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May